Evidence map›Paper›PMID 28927089›Full record

ArticleOncology letters2017

Chronic radiation exposure of neuroblastoma cells reduces nMYC copy number.

Manu Gnanamony, Reuben Antony, Karen S Fernández, Libes Jaime, Julian Lin, Pushpa A Joseph, Christopher S Gondi

Abstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manu GnanamonyDepartment of Pediatrics, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Reuben AntonyUC Davis Comprehensive Cancer Center, Pediatric Hematology and Oncology, UC Davis Children's Hospital, Sacramento, CA 95817, USA.
Karen S FernándezCancer and Blood Diseases Center, 9300 Valley Children's Place FC13, Madera, CA 93636, USA.
Libes JaimeDepartment of Pediatrics, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Julian LinDepartment of Neurosurgery, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Pushpa A JosephDepartment of Pathology, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Christopher S GondiDepartment of Pathology, University of Illinois College of Medicine, Peoria, IL 61605, USA.

Funding

Combination therapy to inhibit neuroblastoma growthR01CA147792 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GONDI, CHRISTOPHER SUMEET BABU · 2010 to 2014
$1.6M
NCI NIH HHS R01 CA147792
6 · The paper itself

Abstract

Neuroblastoma accounts for >15% of cancer-associated mortalities of children in the USA. Despite aggressive treatment regimens, the long-term survival for these children remains <40%. The identification of v-Myc avian myelocytomatosis viral oncogene neuroblastoma-derived homolog (nMYC) gene amplification during diagnosis is associated with poor prognosis in neuroblastoma. There are limited studies examining changes in nMYC copy numbers in response to therapy and its biological effect on cancer cells. The aim of the present study was to evaluate the effect of radiation on nMYC expression and amplification status in high-risk neuroblastoma. The effect of acute (5 Gy) and chronic (25 Gy) radiation on two nMYC-amplified cell lines, SK-N-BE (2) and NB-1691, was investigated. The results demonstrate that, following chronic but not acute radiation, the two cell lines regained their proliferation potential similar to the controls. This increased proliferation was characterized by loss of nMYC mRNA and protein expression. It was also revealed that nMYC loss was accompanied by nuclear localization of c-Myc. Using fluorescent

Indexed as

copy numberneuroblastomaradiationv-Myc avian myelocytomatosis viral oncogene neuroblastoma-derived homolog

Identifiers

PMID28927089
PMCPMC5587969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.